On this page First Author* brings you details of new scientific publications as they are released and reviews the best new journals. We also cover changes in publishers and provide links to author submission guides. PubMed is also covered here. The updates are arranged monthly according to when the announcements were made. Follow the links on the right hand side of this page to view updates by publisher.
*20/02/07: Podcasts and slideshows from BioMed Central's Open Access Colloquium are now available. The colloquium, held on Thursday 8th February, 2007 at the Royal College of Physicians, was entitled Open Access: How Can We Achieve Quality and Quantity? It featured a number of short presentations that reviewed the current state of open access publishing, with focus on several successful case studies such as PLOS and the BMJ. Further, it discussed OA business models, the beneficiearies from OA publishing, and the goals of the OA movement over the next few years. MP3 and Powerpoint files of all talks are now available for public download.
*20/02/07: BioMed Central has launched a new open access journal, Osteopathic Medicine and Primary Care. The journal publishes research on all aspects of family medicine, internal medicine, pediatrics, and obstetrics and gynecology. The journal also covers health service and public health research that addresses primary care issues. BMC journals have also published two new supplements. BMC Evolutionary Biology has published its first supplement: Volume 7 Supplement 1, articles from the "First International Conference on Phylogenomics", held in Sainte-Adèle, Québec, Canada, 15-19 March 2006. BMC Cancer has published its first supplement: Volume 7 Supplement 1, abstracts from the meeting "24th Annual Meeting of the National Cancer Institute of Mexico" held in Mexico City, Mexico, 14-17 February 2007.
*19/12/06: Three BMC journals have recently published new supplements. BMC Bioinformatics has published articles from the Second International Symposium on Semantic Mining in Biomedicine (SMBM), which was held in Jena, Germany, on 9-12 April 2006. The same journal has published the abstracts from the Symposium of Computations in Bioinformatics and Bioscience (SCBB06), which was hosted by Hangzhou, China, between the 20 and 24 of June 2006. BMC Pulmonary Medicine has published its first supplement, entitled Improving outcomes for asthma patients with allergic rhinitis, an effort initiated by the International Primary Care Respiratory Group.
*10/11/06: The BMC journal Microbial Cell Factories has published its first supplement. Volume 5, Supplement 1 consists of abstracts from the meeting "The 4th Recombinant Protein Production Meeting: a comparative view on host physiology", held in Barcelona, Spain on 21-23 September 2006. Microbial Cell Factoriesis a journal dealing with papers on all aspects of the development, use and investigation of microbial cells as factories for production of both natural products and recombinant proteins.
*6/11/06: Biomed Central has announced the launch of the open access Journal of Orthopedic Surgery and Research. This journal is also the official journal of the Chinese Speaking Orthopedic Society. It is ready is to receive manuscripts on all aspects of research related to musculoskeletal issues, via online submission.
*23/10/06: Biomed Central has launched a new journal, Infectious Agents and Cancer. The journal is ready to receive manuscripts on all aspects of the pathogenic mechanisms of chronic infections and progression to oncogenesis.
*12/10/06: Biomed Central has published a new BMC Bioinformatics supplement: the proceedings to "The Third Annual MidSouth Computational Biology and Bioinformatics Society (MCBIOS) Conference. Bioinformatics: A Calculated Discovery", held in Baton Rouge, LA, USA on 2-4 March 2006.
*31/08/06: Biomed Central has launched a new publication: BMC Systems Biology. BMC Systems Biology is now accepting submissions regarding systems-level analysis of biological events, whether experimental or theoretical, at the level of molecules, cells or organisms. The journal especially welcomes quantitative analyses and those that integrate different levels of information to understand how biological systems function or can be perturbed, as well articles involving the modeling or engineering of biological systems, and synthetic biology. Like all BMC journals BMC Systems Biology is open access. BMC has also published a new supplement for Genome Biology. The supplement is titled EGASP '05: ENCODE Genome Annotation Assessment Project. *04/08/06: BioMed Central has launched a new open access, online, peer reviewed journal. Carbon Balance and Management will feature articles on all aspects of the global carbon cycle.*13/07/06: BioMed Central has recently launched a China Gateway network, which features articles co-authored by scientists from China, Taiwan, Hong Kong, or Macao, that have been published in one of their open access journals. BMC have also released a PR brochure in Chinese to appeal to pubilshing Chinese scientists.
*06/07/06: The BMC has announced that 18 of its open access journals will be included in the Medscape Publisher's Circle. Several clinically relevant articles will be selected from each journal every month and uploaded to Medscape from the popular website WebMD, providing clinicians and other medical personnel access to cutting-edge scientific research. For more information, read the BMC press release.
*06/07/06: BioMed Central has launched a new open access, online, peer reviewed journal. Diagnostic Pathology will feature a variety of articles articles on surgical and clinical pathology.
*28/06/06: BioMed Central has launched a new open access, online, peer reviewed journal. The Orphanet Journal of Rare Diseases will feature articles on rare diseases and orphan drugs; clinical trials and research describing new syndromes will be especially encouraged. In more positive news for BioMed Central, they have received their first list of impact factors. The impact factor of 9.71, released for journal Genome Biology, has confirmed the status of Biomed Central as a leading publisher in the field of biology.
*30/05/06: BioMed Central releases four new open access, peer reviewed journals. The journals cover a wide range of subjects but all have a cross-disciplinary focus. Cell Division will publish a broad range of findings in cell-cycle research and to bridge the gap between models of cell cycle regulation and cancer biology; the Journal of Biomedical Discovery and Collaboration will encompass all aspects of scientific information management and studies of scientific practice, with a particular emphasis on biomedical laboratory investigations; Philosophy, Ethics, and Humanities in Medicine invites papers on all aspects of the philosophy of medicine and biology, and the ethical aspects of clinical practice and research. It also considers papers at the intersection of medicine and humanities, including the history of medicine, that are relevant to contemporary philosophy of medicine and bioethics. Finally, the World Journal of Emergency Surgery will examine all aspects of clinical and basic research studies related to emergency surgery (traumatic and non-traumatic) and its allied subjects.
*16/05/06 This month the BioMed Central journal formerly known as Current Controlled Trials in Cardiovascular Medicine (CCTCVM) is re-launched as Trials. The journal is an open access, peer-reviewed, online publication that will encompass all aspects of the performance and findings of randomized controlled trials in medical disciplines. Trials aims to build on the recent statement of the International Committee of Medical Journal Editors to improve the practice of clinical trials by providing a forum focusing on the rationale and design of the trial itself rather than its results.
*BioMed Central announced this month that it will be offering two awards of US $5000 for the highest-quality research published in a any of its open access journals. One of the awards, which will be announced in early 2007, is for biological research, and the other for medical research. More information, including how to nominate articles is available on: http://www.biomedcentral.com/researchawards2006.
*A new journal from BioMed Central, Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It will publish findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology. The full text of articles will be available on PubMed immediately after publications.
*BioMed Central begins to publish the new open-access, peer-reviewed Journal of Cardiothoracic Surgery. The journal aims to provide a forum for the publication and free access of high quality original scientific reports documenting clinical and experimental advances in cardiac and thoracic surgery, and related fields. The intended audience is cardiothoracic surgeons, cardiothoracic anaesthesiologists, cardiologists, chest physicians, and health professionals in related fields.
*The latest new journal to appear on BioMedCentral is Theoretical Biology and Medicinal Modelling. The open-access journal describes itself as 'adopting a broad definition of "biology" and focusing on the theoretical ideas and models to which advances in biology and medicine are giving rise'. It promises swift peer-review and referees on hand to participate in ongoing discussion following the publication of an article.
*New from BioMed Central is the Journal of Occupational Medicine and Toxicology. The open access journal is devoted to the diagnosis, prevention, management and scientific analysis of diseases from the fields of occupational and environmental medicine and toxicology. It also covers the promotion of occupational and environmental health. Also released this month is Substance Abuse, Treatment, Prevention and Policy a journal focusing on all aspects of substance abuse with an emphasis on policy.
*BioMed Central launches this month Implementation Science an open-access, peer reviewed journal focusing on methods of implementing research findings in routine healthcare. Implementation Science will encompass all aspects of research in this field, in clinical, community and policy contexts. Implementation Science will publish a broad range of articles – study protocols, debate, theoretical and conceptual articles, rigorous evaluations of the process of change, and articles on methodology and rigorously developed tools – that will enhance the development and refinement of implementation research. No one discipline, research design, or paradigm will be favoured.
*Biomed Central is launching a new open access journal, Biology Direct. The journal covers a wide range of subject areas, including any aspect of molecular, cellular, organismal, or population biology, as well as methods, theoretical and computational biology, comparative biology, and evolution. The journal has an innovative system of open peer review (see Debates for a brief review).
*BioMed Central is launching a new service, Faculty of 1,000 Medicine (see Debates for a brief review)
*BioMed Central will publish Geochemical Transactions, the online journal of the Geochemistry Division of the American Chemical Society, from January 1, 2006. Geochemical Transactions will become the first open access journal in the field. Authors of recently submitted manuscripts and authors who are planning to submit manuscripts before January 1, 2006, should consult information posted on http://membership.acs.org/g/geoc/.
*BioMed Central has launched two new gateways, in the areas of Neuroscience, Neurology & Psychiatry and Systems Biology . the gateways bring together journals within the subject areas, alongside plus the latest research, news and links to relevant Faculty of 1000 Biology evaluations.
*BioMed Central has launched a new open access, peer-reviewed, online journal, Saline Systems. The journal invites submissions of manuscripts on all aspects of basic and applied research on halophilic organisms and saline environments.
*Another peer-reviewed journal, Cough went to press with BioMed Central in September. The peer-reviewed, open-access journal will accept papers on all aspects of basic scientific and clinical research involving both acute and chronic cough.
*The BioMed Central journal BMC Veterinary Research has released its first issue. The open-access peer-reviewed journal publishes original research articles in all aspects of veterinary science and medicine, including the epidemiology, diagnosis, prevention and treatment of medical conditions of domestic, companion, farm and wild animals, a well as the biomedical processes that underlie their health.
*Biomed Central has also begun to publish the open-access peer-reviewed Journal of Ethnobiology and Ethnomedicine, papers on all areas of Ethnobiology and Ethnomedicine will be considered.
*BioMed Central is broadening its range of publishing subjects and collaboration with its new partnership with the Beilstein Institut to publish the new journal the Beilstein Journal of Organic Chemistry.
*BioMed Central has introduced a new 'highly accessed' logo. This logo indicates that the article concerned has received a large number of accesses relative to its age and the journal in which it was published. Once an article is flagged as highly accessed, it will remain flagged as such, which means that authors can refer to the highly accessed designation when listing their publications.
*19/12/06: Blackwell Publishing has announced the launch of their Best Practice Guidelines on Publication Ethics: A Publisher's Perspective, becoming the first publisher to offer such a comprehensive resource to its journal editors and society partners. The guidelines were created to provide practical advice to editors on the major ethical principles of academic publishing and to help inform the editorial policies of their journals. A broad range of topics are addressed including transparency, disclosure, research integrity, peer review, conflicts of interest and plagiarism.
Dr. Andrew Robinson, Director of Medical Publishing of Blackwell Publishing, has expressed his hope that the guide will provide a basis for the devloping ethical framework of editors. “Today’s editors confront a vast range of ethical dilemmas, and as a leading publisher for societies, where editorial control is so important, we have a duty of care to provide them with the tools to deal with these issues. We needed our guidelines to be flexible enough to change with the expanding ethical scene, and yet provide firm boundaries for editors who address ethical questions on a daily basis.”*04/10/06: At the IEPA Conference in Birmingham this month Blackwell launched a new journal, Early Intervention in Psychiatry. The first issue will be published in February 2006 and the journal invites articles dealing with the early recognition, diagnosis and treatment across the full range of mental and substance use disorders, as well as the underlying epidemiological, biological, psychological and social mechanisms that influence the onset and early course of these disorders. (More details).
*Blackwell is working with Thomson Scientific and ScholarOne to develop a new service incorporating elements of ScholarOne® Manuscript Central™ with Web of Science® and EndNote® that will allow authors to create and submit their manuscript using the same program. Reviewers and readers will also be able to access citation data directly from the manuscript. For more details see Blackwell's press release.
*07/02/07: In the past week, Elsevier has announced the launch of three new journals. The premier issue of the Journal of Clinical Lipidology will be published in March 2007. The full-text of each issue will be available to members of the National Lipid Association and individual subscribers. Abstracts and tables of contents will be open to all.
Elsevier has also announced the future launch of the first journal dedicated to research in technological developments for reducing greenhouse gas emissions. The new journal, titled International Journal of Greenhouse Gas Control, will be published quarterly in association with the IEA Greenhouse Gas R&D Programme.
Finally, Elsevier will launch Biotechnology, the Journal, as the official publication of the European Federation of Biotechnology (EFB) in September 2007. Biotechnology, the Journal will be a cross-disciplinary research and review journal aimed at an audience of academic and commercial bioscientists who are interested not only in science but also in its translation and use.
*08/01/07: In April 2007 Elsevier will launch a new journal entitled the Journal of Hydro-environment Research. This quarterly journal will be a collaboration between Elsevier, the International Association of Hydraulic Engineering (IAHR), its Asia Pacific Division (IAHR-APD) and the Korea Water Resources Association (KWRA). The Journal of Hydro-environment Research provides an international platform for the dissemination of research and engineering applications related to water and hydraulic problems in the Asia-Pacific region. In addition to research articles, the journal will also publish review papers, invited contributions, book reviews and technical communications.
*06/11/06: Elsevier, the publishers of Current Therapeutic Research: Clinical and Experimental 5, a peer-reviewed publication serving an international audience of scientists and clinicians, announces a new section within the journal titled, "Trials from Resource-Limited Settings". As explained in the Elsevier press release, much of the research published today fails to address the needs of the areas hardest hit by epidemics such as HIV. For example, while more than two thirds of the HIV-infected population lives in Africa, only 0.2% of research published in the top 50 biomedical journals comes from that continent. Language and publication bias are pervasive across all medical disciplines. However, with "Trials from Resource-Limited Settings," CTR now makes the inclusion of articles from resource-limited settings a key priority. It is hoped that this new addition will have an impact on therapeutic research efforts far beyond resource-limited settings. The publishers of CTR expect that this direction of focus will build on the inherent strengths of the journal while contributing in a significant way to the medical literature. CTR will continue its commitment of working with authors to refine manuscripts and ensure that well-designed studies are published. As always, the publisher and medical editors will not only collaborate with the authors to standardize formatting and clarify study design and methods but also provide significant assistance to authors for whom English is a second language. For more on the importance of encouraging scientific research performed in and relevant to countries in the developing world, consult First Author’s recent article describing the importance of open access publication to the developing world.
*02/11/06: Elsevier has announced its new partnership with the NLA – National Lipid Association , the leading society for health care professionals who work to reduce the incidence of morbidity and mortality from associated disorders of lipid metabolism. In March 2007, the Association and Elsevier will commence publication of the Journal of Clinical Lipidology as the official publication of the Association. Journal of Clinical Lipidology will present scientific and clinical research from every field involved in lipids and clinical lipidology. The specialty of "lipidology," a multidisciplinary branch of medicine focusing on lipid and lipoprotein metabolism and their associated disorders, is still in its infancy and continues to evolve with the field of medicine as a whole. The field is growing rapidly in response to demographic trends that place an increasing number of Americans at risk for coronary heart disease (CHD) and epidemic levels of obesity concurrent with a surge in new cases of diabetes mellitus. Beginning in March 2007, the full-text of each issue of Journal of Clinical Lipidology will be available online to National Lipid Association members and individual subscribers through its customized website, as well as through Elsevier's online subscription service, ScienceDirect for institutional subscriptions.*30/10/06: Elsevier have been upgrading their search services. The compay announced last week that Scirus has signed an agreement with CrossRef, the cross-publisher linking network, allowing Scirus to collect metadata from hundreds of participating publishers via CrossRef’s new Web Services protocol (more details).
*04/07/06: Elsevier announced today that its Asia Pacific division would partner with the Asia Foundation to provide much-needed medical textbooks to the Health Sciences University of Mongolia. Elsevier's books were donated via the Books for Asia program sponsored by the Asia foundation, which has to date provided 41 million books, software programs, and other critical teaching materials to more than 50,000 institutions in 40 countries since 1954. For more information, see Elsevier's press release.
*31/05/06 Elsevier has announced a new online-only journal, Update on Cancer Therapeutics. Primarily devoted to reviews, the journal will be published quarterly and focus on recent advances in the understanding of anti-cancer drugs, biological agents and the multi-disciplinary management of specific malignancies.
*12/05/06 Elsevier has announced that Scripta Materialia, companion journal to Acta Materialia, has been redesigned in a new letters format. This format is designed to enable rapid publication of cutting edge research in materials science and engineering and provide a clear visual distinction between the two companion journals. Scripta papers will be limited in length and address new results of high current interest and significance, while the Acta papers will remain full length.
*Elsevier has entered into partnership with Key Organics Ltd., a supplier of screening compounds and chemical building blocks. The agreement means that customers will be able to order Key Organics products directly from an entry in the Available Chemicals Directory and the Screening Compounds Directory, Elsevier's databases containing detailed product and pricing information from drug companies around the world.
*Elsevier announced that its free science-specific search engine, Scirus, is expanding its repository search service to Asia-Pacific by partnering with Chiba University to index its institutional repository, CURATOR, and to power the search capability on its site. CURATOR holds 2,000 records in both English and Japanese, including departmental bulletins, technical reports, preprints and articles, theses and research papers (more details).
*Elsevier's molecular database, the Compound Index, hosted on Elsevier MDL’s DiscoveryGate® platform, is now cross-indexed to the PubChem database of small molecule data, designed to support links to outside chemical information resources (more details).
*Elsevier has launched a new new drug tracking and analysis tool, Inteleos. Inteleos allows users to track and analyse drug activity from late-phase preclinical development through to launch and post-marketing studies using Elsevier's database of drugs and pharmaceutical companies. It is also possible to monitor licensing, or merger and acquisition activities.
*Elsevier has announced the launch of a new citation analysis tool for Scopus, their abstract and database citation tool. (For more details see the Debates page) .
*Elsevier announced this month that it has bought MediMedia’s professional medical publishing businesses (MediMedia MAP). This expands existing publishing programs and digital services, accelerates growth, and meets the demand for structured continuing education amongst medical and allied healthcare professionals worldwide. MediMedia MAP is a key provider of medical information in rapidly growing international healthcare markets. Based in France, Spain, the US, the UK, Italy and Mexico, MediMedia MAP publishes the prestigious imprints of Masson, Doyma and Netter, providing medical books, journals and reference information for the practitioner market as well as continuing medical education and pharmaceutical industry-sponsored communications.
Elsevier has also announced a new publishing partnership with the British Mycological Society (BMS). As of January 2006 Elsevier will publish the Society's journals Mycological Research, Mycologist and Field Mycology.
*20/02/07: Nature Publishing Group (NPG) and AstraZeneca have launched of Nature China, a new web based publication promoting scientific research published in mainland China and Hong Kong. In the past decade, the output of research papers from China, in the Thompson ISI database, has soared from 10,000 papers a year to over 80,000. Nature China will focus on these very high impact papers by scanning the top journals and seeking the support of the user community to find the best research papers. The editor of Nature China will select the best research, recently published, and provide a short summary of the results. By organizing this research into a comprehensive, regularly updated, one-stop web portal, Nature China will help scientists and science policy makers find information on the most significant research coming out of China.
*07/02/07: Nature Publishing Group (NPG) and the Society for Mucosal Immunology (SMI) have announced a new publishing partnership. In the fall of 2007, NPG and SMI will launch a new publication, Mucosal Immunology.Mucosal immunologists focus on the sites at which most antigens enter - the mucosal surfaces of the gastrointestinal, respiratory and urogenital tract. Scientists of mucosal immunology aim to better understand diseases such as AIDS, asthma, and inflammatory bowel disease. Mucosal Immunology will be the first journal dedicated to this field of science. Further, Mucosal Immunology aims to provide a primary method of communication for the SMI governing board and its members through the publication of society news, announcements of planned meetings and conferences, discussions of policy concerns and advertisements for job and training opportunities. SMI currently represents a diverse group of more than 700 scientists and clinicians from 37 countries.
*07/02/07: Immunology & Cell Biology has joined the NPG collection of leading academic journals, adding publicity and convenience to readers and authors via the Nature website. Advance Online Publication ensures fast publication times and new article types make the journal more accessible and relevant to the community than ever before. Immunology & Cell Biology spans the breadth of immunology, with a particular emphasis on the cell biology of the immune system. Areas that are covered include cellular immunology, innate and adaptive immunity, immune responses to pathogens, tumour immunology, immunopathology, immunotherapy, immunogenetics and immunological studies in humans and model organisms.
*31/01/07: The Bill and Melinda Gates Foundation have teamed up with NPG to present a custom publication, Improved Diagnostic Technologies for the Developing World. The publication gives findings of the Global Health Diagnostics Forum, in partnership with the RAND Corporation, to determine global health diagnostics needs. The series of 8 papers is open acces via the Nature website. In the publication's foreward, the reason for publishing this series of papers is laid out by representatives of both the Gates Foundation and The RAND Corporation.
An essential component of evaluating and improving global health is access to appropriate diagnostic tools. Through this series of papers we hope to further the dissemination of current knowledge on global health diagnostic needs for the conditions that most severely affect those living in the developing world.
*16/01/07: The Nature Publishing Group has launched Nature Education, a publication designed to provide novel educational resources for undergraduate science students and their professors. Building upon Nature’s reputation with scientists as a source of cutting edge information, Nature Education will focus on digital teaching materials in biology, chemistry and physics.
“Now is the right time to redefine undergraduate classroom education worldwide,” said Vikram Savkar, Nature Education’s newly appointed publishing director. “Instructors and students are thirsty for learning environments that move beyond traditional textbooks and even course management systems to provide a highly interactive and personalized experience that simultaneously builds understanding, inspires career and research aspirations, and connects the student o a worldwide community of likeminded thinkers. With its excellent content, brand, global reach, and community of practicing scientists, NPG and Macmillan are superbly positioned to catalyze and capitalize on a radical shift in education.”
*19/12/06: Immunology and Cell Biology has joined the Nature Publishing Group's portfolio of leading academic and society journals. The merge will ultimately give the journal's readers and authors increased visibility and linking through nature.com. Advance Online Publication ensures fast publication times and new article types make the journal more accessible and relevant to the community than ever before.
Immunology and Cell Biology spans the breadth of immunology, with a particular emphasis on the cell biology of the immune system. Areas that are covered include, but are not limited to, cellular immunology, innate and adaptive immunity, immune responses to pathogens, tumour immunology, immunopathology, immunotherapy, immunogenetics and immunological studies in humans and model organisms (including mouse, rat, Drosophila etc).
*11/12/06: The Nature Publishing Group has launched two new collaborative pathways. The first, the Functional Glycomics Gateway, is a joint effort between NPG and the Consortium of Functional Glycomics. It provides news and reearch data from the Consortium's activities, and is supplemented monthly with an editorial section relevant to the interests of structural biologists, biochemists, and cell biologists.
The Pathway Interaction Database is a peer-reviewed collection of information about biomolecular interactions that occur in human cellular signalling pathways. This pathway is a collaboration between NPG and the US National Cancer Institute and targets cell biologists, biochemists, computational biologists and bioinformaticians.
*10/11/06: To commemorate the first anniversary of the launch of Nature Clinical Practice Rheumatology, this month's edition will include a special web resource focusing on the future of biologic therapy in the rheumatic diseases. The resource will include articles that have been published in NPG journals since 2005, including reviews, editorials, and original research articles. Content will be available for free throughout November 2006.
*18/10/06:The Nature Publishing Group (NPG), in collaboration with the International Society for Microbial Ecology (ISME), has launched a new international publication. ISME: The Multidisciplinary Journal of Microbial Ecology will be available in print and online from May 2007. The journal will be dedicated to advancing the research field of microbial ecology, a topic that is pivotal to our understanding of the world's diverse natural and manipulated ecosystems. For the NPG press release read here.
*04/10/06:The Nature Publishing Group (NPG) has launched Nature Nanotechnology, a journal focusing on all aspects of nanoscience and nanotechnology. The inclusion of an editor from the Asia-Pacific region, Dr. Ai Lin Chun, is a first for an NPG publication. A consultant editor from Tokyo, Dr. Adarsh Sandhu, has also been employed by the journal. Dr. Chun and Dr. Sandhu’s presence reflects the strength of Japanese scientists in the topic area. The first issue of Nature Nanoscience will contain a special feature entitled, ‘What is nanotechnology?’
*Nature has announced that access will now be enabled through ATHENS, the service that provides remote access to academic resources. Nature is also working towards making its services compliant with the open source authentication service Shibboleth.
*07/08/06: NPG has announced release of its first all Japanese publication, Nature Digest. The monthly journal includes news, news features, and opinion articles translated into Japanese from nature.com. Further, commissioned pieces written originally in Japanese will be included, along with a section studying scientific English and analyzing the translation of Japanese scientific articles into English.
*17/07/06: A new publication from the Nature Publishing Group, Nature Nanoscience, is now available for preview. The NPG has announced a call for relevant papers. The journal will officially be launched in October 2006 and will feature articles from all areas of nanotechnology and nanoscience.
*12/07/06: The National Library of Medicine in Bethesda, Maryland, USA has announced that all 8 of the Nature Clinical Practice Journals will be indexed in Medline. The NLM consults a panel of experts in the field of biomedicine to shortlist journals that should be indexed. Nature's four most recent journals in the Clinical Practice series, covering the topics of Neurology, Endocrinology & Metabolism, Nephrology and Rheumatology were released in November 2005. The original four journals in the Clinical Practice series were indexed by Medline in July 2005. They were released in November 2004 and cover the topic areas of Oncology, Cardiovascular medicine, Urology and Gastroenterology & Hepatology,
*5/07/06: The Nature Publishing Group has launched a groundbreaking database for the publication and open discussion of laboratory protocols: Nature Protocols. Approximately 400 standard laboratory procedures have been slated for publication in Nature Protocols in 2006. The database will offer step-by-step explanations of a given procedure, highlighting key steps, offering troubleshooting advice, and providing a forum for public refinement and commentary on all posted procedures. Two distinct aspects to the project will be available: Nature Protocols will consist of peer-reviewed, published protocols and will be availble via institutional license. The Protocols Network, available free of charge, will supplement the former, providing a public forum for posting of non-peer reviewed techniques that have been developed in their laboratories. In both cases public feedback will be encouraged, such that novel techniques and developments can continually be shared. For more information, see the NPG's own press release.
*28/06/06: Macmillan publishing, the parent company of the Nature Publishing Group, has launched Macmillan Medical Communications (MMC). MMC is an agency designed to provide novel campaign strategies for the efficient publication and dissemination of information in pharmaceutical, biomedical, and healthcare applications. MMC will specialize in niche audiences throughout the world, specifically in non-English speaking countries in the Far East, Latin America and India. One feature that will be provided is the translation of NPG publications into local languages. For more information on MMC, and on its first live service, the collaborative news site www.dissectmedicine.com, consult the Macmillan press release. Further, today's First Author* article on Open Access publishing in developing nations may elucidate the potential benefits of MMC in the developing world.
*24/05/06: A new gateway bringing together information on cell motility in the gastrointestinal tract, GI Cell Motility was announced by Nature this week. The gateway features textbook-style articles as well as synopses aimed at those outside the specialisation, reviews of current literature and case studies. The gateway is divided into three parts: Oral cavity, pharynx and esophagus - (available now); stomach, small bowel, hepatobiliary and pancreatic ducts (in preparation); and colon and anorectum (in preparation). All sections will make use of graphics and audiovisual material, contain interactive 'self-testing' sections, and cross reference literature in PubMed and other databases.
*11/05/06: Nature today announced the launch of a new Neuroscience Gateway. Developed in partnership with the Allen Institute for Brain Science the gateway's more interesting feature is the Allen Brain Atlas, a publicly accessible project that aims to to create a detailed cellular-resolution, genome-wide map of gene expression in the mouse brain and which will have completed mapping gene expression in approximately 20,000 genes by mid 2006. Other functions of the gateway, similarly to Nature's previous Cell Signaling, Signaling Gateway and Omics Gateway are to highlight recent news and research related to Neuroscience published in NPG journals and to highlight forthcoming conferences and vacancies.
*A new website from Nature Methods, Application Notes targets laboratory scientists, so far focusing mainly on the life sciences. The Notes are non-peer reviewed essays, downloadable in PDF format, issued by suppliers to describe the technical performance of new products or innovative applications of laboratory technologies.
*Nature has launched the latest in its series of blogs: 'The Skeptical Chymist' invites 'spirited' participation from Nature staff, contributors and readers. So far, discussion has ranged from the allegedly magical effects of Fullerence C60 in anti-wrinkle cream, lithography on the nano-scale and electrophilic platinum complexes. There is also news on funding, conferences, and the odd rude comment about physicists!
*Beginning from October 2006, Nature will publish a new cross-disciplinary journal, Nature Nanotechnology covering all areas of nanotechnology and nanoscience. The journalis designed to encourage the exchange of ideas between physical, material and and life scientists, and engineers. Nature is issuing a newletter to keep potential subscribers or editors informed of developments (register).
*Due to launch in January 2007, Nature Photonics will cover all areas of photonics and optoelectronics and is designed to provide a bridge between academia and industry.
*Nature has now launched their Podcast in earnest and is asking listeners to complete a survey evaluating the service to be entered into a draw to win an iPod. The podcast, begun in October this year, has already risen in popularity to become one of the top science podcasts, attracting well over 30,000 weekly downloads (more details).
*Nature announced this month that they would be merging their representative offices in Japan, Hong Kong and Australia to become NPG Nature Asia-Pacific, handling editorial, marketing, sales, print and web production for the Group in the region. The editors of two new Nature-branded primary research journals, Nature Nanotechnology and Nature Photonics, will now be located in Tokyo and more editorial staff are expected to be based in Japan and China in future (more details).
*Nature has caught the blogging bug: launched this month, Nascent is a blog on web technology and science that has so far focused on issues such as 'are blogs academic publications?' and the possibilities of social referencing tools such as Connotea. Action Potential the neuroscience blog launched the same day covers conferences and events such as the Dalai Lama's controversial SfN lecture and the latest papers to appear in Nature Neuroscience. Action Potential seems to have attracted more commentary so far, and one reader's comment was peer-reviewed and published in Nature Neuroscience, a move guaranteed to attract more reader participation. Finally, the genetics blog Free Association has been very recently begun, so far consisting of links to the latest papers published online in Nature Genetics.
*Three new journals in the clinical practice series are due to be launched in November 2005. All are published monthly in print and online and will include editorial and opinion pieces, highlights from and reviews of current literature, commentary on the application of recent research to clinical practice, and case studies. the new publications are:
NPG has announced that from January it will publish the Journal of Investigative Dermatology, on behalf of the Society for Investigative Dermatology. The JID had an impact factor of 4.238 for 2004, making it the top-ranking dermatology journal according to the ISI ranking.
The first issue of Nature Physics is now available online. The new journal covers all aspects of Physics, this issue featuring articles in the fields of optics, quantum information science, accoustics, and superconductivity.
Nature has formed a partnership with the Shanghai Institutes for Biological Sciences (SIBS) to publish Cell Biology, a leading English-language Chinese journal.
*PubMed has introduced a new limitation option for its search function. The search can be narrowed down to papers published within a specified data range, to papers within particular subject areas, groups of journals or by other types of publication. It is also possible to refine the search based on the characteristics of the subjects involved: it is possible to specify human or animal subjects, male or female, and age-range. A final useful addition is the capacity to run a search identifying only those papers of which the full text is available (more details).
*PubMed has refined its search by introducing a new citation matcher which allows you to enter any available details about a paper and use the search to match it in the PubMed database.
*PubMed has now fully introduced its own RSS feed. The feed is accessed from the search results page and can bring you updates by author, journal, or keyword.
Two new publications are now available on PubMed MC Veterinary Research and Biochemical Journal (more details). For more news related to PubMed, see the NLM Technical Bulletin.
In most other journals, publication of a research paper marks the end to a research process. In PLoS ONE, as soon as an article is published, a conversation between authors and readers can begin. There might be a question about a method that is described in the article, a link to another useful work or resource that can be added, or an alternative interpretation that can be offered for some of the results. In each case, readers and authors can respond to the addition, and everyone else can benefit from the resulting dialogue.
PLoS ONE was first described to the research community back in June 2006, and the response to the proposal has been enthusiastic and sustained. Although PLoS ONE opened its doors to manuscript submissions only in August, it already receives in excess of 100 submissions each month and launches with the publication of 100 peer-reviewed research articles. The volume of articles is unprecedented for a journal launch, and is an indication of the strong support within the research community for the PLoS ONE approach.
The articles published have been peer-reviewed under the guidance of an extensive academic editorial board, and cover a broad range of research topics, from basic molecular science to clinical studies. Of course, in accordance with the guidelines of PLOS, the articles are published under an open access license.The beta version of PLoS ONE that has launched is a work-in-progress. PLoS wishes the community to help shape PLoS ONE, and the underlying publishing platform, into its most valuable form. The software is open source, and will form the first part of an innovative and flexible publishing system that will be developed over the next two years and will be available to all groups for storing, disseminating, and sharing literature and data. PLoS ONE hopes to accelerate the pace of scientific research, as publication is rapid and interactive. It presents a way to share not only the results of research but also the responses, ideas, and opinions of fellow researchers as well.
*03/10/06: The 2007 launch of PLoS Neglected Tropical Diseases was announced last month. The open access peer reviewed journal is supported by a $1.1 million grant from the Bill & Melinda Gates Foundation and has the ambitious aim of 'promoting science, policy, and advocacy for diseases of the poor'. As well as raising the profile of neglected diseases such as elephantiasis, river blindness, leprosy, hookworm, schistosomiasis, and African sleeping sickness, PLoS NTD aims to build biomedical research capacity within endemic countries.
*29/08/06: PloS has seen encouraging results from their new OA publication, PLoSONE. This journal covers all aspects of science and medicine, and is sold on the fact that peer review decisions are made extremely rapidly--within days. Since it began accepting submissions on the 4th of August, it has received over 70 papers.
*26/05/06: PLoS has launched a new open access, peer reviewed journal, PLoS Clinical Trials, dedicated to reporting clinical trials in all areas of medicine. The journal allows readers to send 'e-letters' commenting on articles as they read. An editorial in the first issue explains that the journal forms part of an initiative to encourages universal disclosure of clinical trials in order to combat the bias arising from the tendancy to publish only those trials that report positive or significant effects. A recent article published by ICMJE in JAMA urged the use of registration of trials, arguing that this would prompt the full and transparent disclosure of their results. BioMed Central also responded to the call for action earlier this month, relaunching their own Trials journal.
*03/01/06 Springer has launched the Journal of Robotic Surgery, to be published four times each each from January 2007. The journal will be the first publication to focus exclusively on the medical use of robotic techniques in urology, cardiac surgery, gynecology, ENT, neurosurgery, and general surgery and will make use of a variety of techniques, including simulation and imaging and video. The journal will appear online on a subscription/ pay-per-view basis before the print issue, or authors can choose to have their articles freely available immediately under the Springer Open Choice model.
*Springer has entered into partnership with the University of Zhejiang Press, China, to publish their series of journals outside mainland China.
Journal of Zhejiang University SCIENCE A (JZUS-A) covers research in Computer and Electrical Engineering and Electronics, Information Sciences, Applied Mathematics and Physics, and topics related to Mechanical and Civil Engineering, Environment and Energy, Materials Science and Chemical Engineering etc.
Journal of Zheijang University SCIENCE B - Biomedicine, Biotechnology and Biochemistry (JZUS-B) covers research in Biomedicine and Biotechnology and Biochemistry and topics related to life science subjects, such as Plant and Animal Sciences, Environment and Resource etc.
Both journals publish research articles, reviews and science letters. Manuscripts are peer reviewed by international editorial boards.
*Springer has released a series of new handbooks in the field of engineering, covering a wide range of topics, from nanotechnology and photonics to robotics and accoustics.
*New journals launched by Springer this month are: Mycological Progress, the first articles from which are now available online, and Natural Medicines, a Japan-based journal focusing on all aspects of naturally occuring medicines from cultivation to biochemistry.
*Springer this month launched its Online Archives Collection. The archive comprises a total of 1,200 journals formerly published by Kluwer, as well as, all content from Volume I, Issue 1, where available, from both the former Springer-Verlag and Kluwer. the subject areas covered include medicine, materials , physical and life sciences. Abstracts are mainly freely available, but access to references is restricted and the artciles are pay-per-view, at a price $30.
*Springer has been expanding its scope of collaboration. During July the publishing company signed cooperative agreements with the Chinese publishers Science Press and Higher Education Press to jointly publish 36 English-language journals, including the prestigious Chinese Science Bulletin as the ‘Chinese Library of Science’. In a similar agreement, Springer and MAIK Nauka/Interperiodica announced an expansion of the translation of Russia journals into English. This will form part of the online ‘Russian Library of Science’ including Journal of Experimental and Theoretical Physics and Physics of the Solid State. In September, Springer announced that it would also be entering into partnership with the Polish publishing house Central European Science Journals (CESJ), based in Warsaw. Existing acclaimed journals of Central and Eastern European societies and other institutions will be co-publish, aiming to achieve a wider dissemination of Central and Eastern European research results. During the next few years, the number of co-published journals in a variety of disciplines is intended to reach approximately 40 and will cover societies and institutions in Poland, Hungary, the Czech Republic, Slovakia, Romania, Bulgaria, the former Yugoslavia and Albania.
*23/05/06 Nature Protocols, a new service due to be launched by NGP in June 2006 is now available as a preview. The aim is to be to deliver laboratory protocols as an interactive online resource for bench researchers.
Nature Protocol's brief, according to editor Katharine Barne, is to evolve alongside constantly changing protocols, providing 'both a source of high quality protocols scientists can trust and a forum for scientists to exchange information on the use of protocols'. Protocols are presented in a ‘recipe’ style: from the examples available (Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression and Tricine-SDS-PAGE) this means that, while the body of the paper is presented in a conventional journal style, essential elements of the process are flagged up with a ‘critical step’ sign, ‘timing’ and ‘pause points’ indicate the length of the experiment, and ‘troubleshooting’ gives tips to solve potential problems that could arise at various stages. The database of protocols will be fully searchable and users will be enabled to add comments.
The core content on the Protocols site will be commissioned by the editorial team, but the site will also include supplementary methods published online from other NGP journals. Protocols are already published by Nature Methods and this journal will be integrated into the Nature Protocols service, along with services like the new database, Nature Methods Application Notes, which features supplier protocols. Protocols will be commissioned that address ‘outstanding biological and biomedical science research questions’, but the resource will include protocols grounded in chemistry or physics that have applications in biological science. Authors of protocols published previously as supplementary methods are responsible for posting their own papers onto the ‘community’ section of the site, and therefore these papers will not be further edited.
Access to the site after its emergence from Beta phase will vary depending on the content being accessed. While peer-reviewed, commissioned protocols are accessible by subscription or by purchasing individual articles, non-peer-reviewed content, presumably including previously peer-reviewed supplementary methods published online, will be freely available.
Nature Protocols will be in competition with Wiley’s long-standing publication Current Protocols. While Nature Protocols is online-only, Current Protocols is offered in a range of formats including print and CD-ROM, so it is likely that the two will coexist, offering more innovative and traditional formats respectively. One useful feature of the Current Protocols site is the option to view videos of protocols. Hopefully, this is something that will also be available on the Nature site, perhaps in combination with new technologies, such as podcasting, which NGP has already successfully made use of to present news and discussion.
* Nature Chemical Biology was launched in June 2005, and has just published its fourth issue. As the editorial to the first issue points out, Chemical Biology has increasingly become recognised as an important target for funding and research, driven by advances in fields such as neurobiology, cell signaling and drug delivery. The aim of the new journal is to reflect the diversity of the discipline. To this end, the journal is divided into four sections: Chemical Synthesis, Chemical Mechanisms in Biology, Expanding Biology through Chemistry and Expanding Chemistry through Biology. Reviews and editorials serve to bring together this diverse content and highlight their relevance for non-specialist readers.
An interesting feature of the new journal is its visual element. Graphical abstracts are used to depict not only chemical structures, but also biological processes, experimental procedures, and results. This element fits well with some of the new online features of Nature Chemical Biology. The journal automatically deposits published papers in PubChem, an NIH database that catalogues the biological activities of small molecules as part of the Molecular Libraries Roadmap Initiative. There are various ways of searching this database, by names, abbreviations or bioassay descriptions, but also by sketching the chemical structure of a compound using the drawing program, SMILES, which is freely available from the website. Other databases in which the journal stores material include BIND: the Biomolecular Interaction Network Database, a compendium of interactions between biologically relevant molecules and PDB: the universal deposition site for data from x-ray crystallographic and NMR studies, as well as Swissprot for protein sequences and GenBank for DNA sequences. A final feature of Nature Chemical Biology online is its direct linking to Nature’s new bibliographic resource, Connotea (read our review of Connotea). You can add a citation from this journal to your Connotea library by selecting ‘save this link’ from the viewing options.
Nature Chemical Biology provides a valuable new resource linking chemistry and biology and its strong visual element and innovative use of online resources helps to bring together the wide range of topics that fall within its remit as well as linking out to related disciplines.